Pinnacle Associates’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-964,759
| Closed | -$14.6M | – | 781 |
|
|
2022
Q3 | $14.6M | Sell |
964,759
-69,093
| -7% | -$1.05M | 0.34% | 87 |
|
|
2022
Q2 | $7.75M | Buy |
1,033,852
+2,787
| +0.3% | +$20.9K | 0.17% | 150 |
|
|
2022
Q1 | $9.38M | Buy |
1,031,065
+290,802
| +39% | +$2.65M | 0.17% | 157 |
|
|
2021
Q4 | $5.2M | Buy |
740,263
+49,984
| +7% | +$351K | 0.09% | 219 |
|
|
2021
Q3 | $7.87M | Sell |
690,279
-6,925
| -1% | -$78.9K | 0.15% | 167 |
|
|
2021
Q2 | $11.2M | Buy |
697,204
+8,717
| +1% | +$140K | 0.2% | 137 |
|
|
2021
Q1 | $12.3M | Sell |
688,487
-57,710
| -8% | -$1.03M | 0.23% | 119 |
|
|
2020
Q4 | $10.1M | Buy |
746,197
+222,137
| +42% | +$3M | 0.2% | 127 |
|
|
2020
Q3 | $6.17M | Sell |
524,060
-13,110
| -2% | -$154K | 0.15% | 160 |
|
|
2020
Q2 | $7.93M | Buy |
537,170
+117,447
| +28% | +$1.73M | 0.2% | 130 |
|
|
2020
Q1 | $5.67M | Sell |
419,723
-50,902
| -11% | -$687K | 0.17% | 140 |
|
|
2019
Q4 | $11.4M | Buy |
470,625
+15,875
| +3% | +$384K | 0.25% | 109 |
|
|
2019
Q3 | $8.74M | Buy |
+454,750
| New | +$8.74M | 0.21% | 132 |
|